Craig A Johnson
CIK 1370348 · Sr. VP, CFO and Secretary · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$252.4K
Companies
6
Total Filings
72
Lifetime Open-Market Net
-$5.65M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Director | 14,592 | $15.82 | $230.8K | $0 | 4 | 2026-06-08 |
| HRTX | Director | 53,960 | $0.40 | $21.6K | -$13.6K | 18 | 2026-02-03 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 0 | $58.70 | $0 | -$5.61M | 16 | 2024-01-23 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Director | 12,000 | $6.22 | $74.6K | $0 | 11 | 2022-07-12 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 3,000 | $1.12 | $3.4K | $51.0K | 5 | 2020-12-31 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | Director | 1,000 | — | — | -$75.7K | 8 | 2012-06-20 |
Recent Filings · Page 3 of 8
72 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-25 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | — | -$2.87M | EDGAR |
| 2021-01-20 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +1,475 | $0 | EDGAR |
| 2020-12-31 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +3,000 | $51.0K | EDGAR |
| 2020-12-23 | HRTX | Grant (A) | +3,000 | $0 | EDGAR |
| 2020-12-14 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-10 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-21 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | — | -$1.01M | EDGAR |
| 2020-01-13 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-07 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2019-12-23 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.